Insiders Buying Bristol-Myers Squibb And 3 Other Stocks
Portfolio Pulse from Avi Kapoor
Insiders at Bristol-Myers Squibb, Matador Resources, First Busey, and DMC Global have recently made notable stock purchases. Bristol-Myers Squibb's CEO acquired shares amid positive trial data for a cancer treatment. Matador Resources' CEO purchased shares following strong quarterly results. First Busey's Director bought shares after the company posted upbeat earnings. DMC Global's Director made purchases despite the company's downbeat third-quarter results. Insider buying can signal confidence in the company's prospects or undervaluation.
December 08, 2023 | 12:05 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
DMC Global Inc. Director James Oleary bought 5,000 shares at $16.39 each despite the company's recent downbeat third-quarter results.
The director's purchase in the face of poor quarterly results could be seen as a contrarian move, and while it may signal confidence, the recent negative results could temper short-term stock movement.
CONFIDENCE 60
IMPORTANCE 40
RELEVANCE 50
POSITIVE IMPACT
Bristol-Myers Squibb CEO Christopher Boerner purchased 2,000 shares at $49.78 each, signaling confidence especially with positive Phase 3 trial data for a cancer treatment.
The CEO's purchase, combined with positive trial results, could be seen as a strong endorsement of the company's future, potentially leading to a short-term positive impact on the stock.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
First Busey Corporation Director Stanley Bradshaw bought 4,200 shares at $23.06 each, following the company's positive quarterly earnings announcement.
The director's purchase after a positive earnings report could suggest a good investment opportunity, potentially leading to a short-term positive impact on the stock.
CONFIDENCE 65
IMPORTANCE 50
RELEVANCE 60
POSITIVE IMPACT
Matador Resources Chairman and CEO Joseph WM Foran acquired 2,000 shares at $54.30 each after the company reported strong quarterly results.
The CEO's stock purchase post strong earnings report may indicate his belief in the company's undervaluation or future growth, suggesting a potential short-term positive impact on the stock.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70